John Trizzino
President presso NOVAVAX, INC.
Patrimonio netto: 133 706 $ in data 31/03/2024
Provenienza dei contatti di primo grado di John Trizzino
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 60 | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
41
| Subsidiary | Biotechnology | 41 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.
14
| Subsidiary | Medical Specialties | 14 |
| Public Company | Medical Distributors | 13 | |
3
| Public Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John Trizzino tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing General Counsel Private Equity Investor | |
Micro Bio Medics, Inc.
 Micro Bio Medics, Inc. Medical DistributorsDistribution Services Part of Henry Schein, Inc., Micro Bio Medics, Inc. is a private company that distributes medical, dental, and hospital equipment. The company is based in Pelham Manor, NY. The company was founded by Michael John Brooke. Micro Bio Medics was acquired by Henry Schein, Inc. on August 01, 1997 for $72.48 million. | Medical Distributors | Corporate Officer/Principal Director of Finance/CFO President | |
| PROGRESSIVE CORPORATION | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| AETNA | Managed Health Care | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| GENVEC INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Chairman | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| CRH MEDICAL CORPORATION | Medical/Nursing Services | Chairman Director/Board Member Corporate Secretary | |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Sales & Marketing President | |
| MAXCYTE, INC. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President Founder President | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Operating Officer | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Chief Operating Officer Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree Director/Board Member Director/Board Member Graduate Degree Doctorate Degree Undergraduate Degree | |
| Lehigh University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Masters Business Admin | |
| University of Iowa | College/University | Graduate Degree Undergraduate Degree | |
| University of Calgary | College/University | President Doctorate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| West Virginia University | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Operating Officer Director/Board Member | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
| US Department of Health & Human Services (DC) | General Government | Corporate Secretary Corporate Officer/Principal President | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chairman Director/Board Member | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Operating Officer | |
| Caligor Medical & Office Supply Co. | Corporate Officer/Principal President | ||
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Corporate Officer/Principal Founder | |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 45 |
| Regno Unito | 4 |
| Canada | 4 |
Settori
| Health Technology | 24 |
| Consumer Services | 16 |
| Finance | 6 |
| Health Services | 3 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 473 |
| Corporate Officer/Principal | 219 |
| Independent Dir/Board Member | 126 |
| Chairman | 122 |
| President | 97 |
Contatti più connessi
| Insiders | |
|---|---|
| David Mott | 45 |
| James Cavanaugh | 38 |
| Norman Matthews | 35 |
| Peter Greenleaf | 31 |
| Rajiv Indravadan Modi | 31 |
| Louis Sullivan | 31 |
| Gail Boudreaux | 30 |
| David Baltimore | 27 |
| Gary Evans | 25 |
| Sven Arne Andréasson | 24 |
| George Milne | 24 |
| Barbara Hackman Franklin | 22 |
| Philip Laskaway | 22 |
| Todd R. Patrick | 22 |
| Wayne T. Hockmeyer | 22 |
- Borsa valori
- Insiders
- John Trizzino
- Connessioni Società
